Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-10 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.490 | -2.700 | -1.2100 | ||||
REV | 304.880M | 276.659M | -28.221M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
NVAX | Novavax | 203.00 | 1.66 | 0.82% | 14.9B |
You can purchase shares of Novavax (NASDAQ: NVAX) through any online brokerage.
Other companies in Novavax’s space includes: Neurocrine Biosciences (NASDAQ:NBIX), CureVac (NASDAQ:CVAC) and Amgen (NASDAQ:AMGN).
The latest price target for Novavax (NASDAQ: NVAX) was reported by HC Wainwright & Co. on 2021-03-12. The analyst firm set a price target for 317.00 expecting NVAX to rise to within 12 months (a possible 57.45% upside). 25 analyst firms have reported ratings in the last year.
The stock price for Novavax (NASDAQ: NVAX) is $201.34 last updated Today at 8:00:03 PM.
There are no upcoming dividends for Novavax.
There is no upcoming split for Novavax.